Acute Stroke Clinical Trial
— SEACOASTOfficial title:
Title : SEACOAST 1 SEdAtion With COllAteral Support in Endovascular Therapy for Acute Ischemic Stroke 1: a Randomized Controlled Phase 2B Clinical Trial
SEACOAST 1 is a prospective, randomized, blinded endpoint trial comparing collateral vigor and clinical outcomes, with different forms of GA in patients with acute ischemic stroke due to anterior circulation large vessel occlusion (LVO) undergoing mechanical thrombectomy. The study compares GA with normocarbia (GAN) versus GA with mild hypercarbia (GAH), with a primary outcome of collateral robustness at measured at catheter angiography and clinical efficacy as secondary outcome. It is anticipated that the SEACOAST 1 will be followed by a larger, pivotal trial, SEACOAST 2, with primary clinical endpoints, in which the best method of GA identified in SEACOAST 1 is compared with the alternative strategy of anesthesia care (MAC) with minimal or no sedation. The current study focuses uppn SEACOAST 1, which is to be conducted in University of California, Los Angeles Ronald Reagan Medical Center and Santa Monica Medical Center. All acute stroke patients who arrive to one of these two stroke centers and are deemed eligible for thrombectomy will be considered for the proposed study. Physician-investigators will determine study eligibility. Informed consent to participate in the study will be obtained from legally authorized representatives or competent patients. For non-competent patients without on-scene legally authorize representatives, the consent process will utilize enrollment in emergency circumstances with exemption of informed consent (EFIC).
Status | Recruiting |
Enrollment | 90 |
Est. completion date | January 1, 2025 |
Est. primary completion date | January 1, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 110 Years |
Eligibility | Inclusion Criteria: 1. Age =18 2. NIHSS = 6 within 0-16h or NIHSS = 10 within 16-24h 3. Anterior circulation large vessel occlusion (ICA, M1, M2) 4. ASPECTS score = 6 within the first 6h, or DEFUSE trial imaging criteria within 6-16h; or DAWN trial clinical/imaging mismatch criteria within 16-24h 5. Premorbid modified Rankin Scale (mRS) 0-2 6. Patient deemed candidate for mechanical thrombectomy with anticipated groin puncture within 24 hours of last known well and within 90 min of ED arrival Clinical Exclusion Criteria: 1. Intubation in ED prior to anesthesiologist evaluation, or intubation for any other medical reason other than planned thrombectomy 2. Rapid neurological improvement, suggestive of revascularization 3. Known serious sensitivity to radiographic contrast agents. 4. Current participation in another investigational drug or device treatment study. 5. Renal Failure as defined by a serum creatinine > 2.0 mg/dl (or 176.8 µmol/l) or Glomerular Filtration Rate [GFR] < 30. 6. Subject who requires hemodialysis or peritoneal dialysis, or who have a contraindication to an angiogram for whatever reason. 7. Life expectancy of less than 90 days. 8. Clinical presentation suggests a subarachnoid hemorrhage, even if initial CT or MRI scan is normal 9. Subject with a co-morbid disease or condition that would confound the neurological and functional evaluations or compromise survival or ability to complete follow up assessments. 10. Subject currently uses or has a recent history of illicit drug(s) or abuses alcohol (defined as regular or daily consumption of more than 4 alcoholic drinks per day. 11. Septic or cardiogenic shock with severe life-threatening hypotension Imaging Exclusion Criteria: 1. Computed tomography (CT) or Magnetic Resonance Imaging (MRI) evidence of acute intracranial hemorrhage on presentation. 2. CT or MRI evidence of mass effect or intracranial tumor (except small meningioma). 3. CT showing hypodensity or MRI showing hyperintensity involving greater than 1/3 of the middle cerebral artery (MCA) territory (or in other territories, >100 cc of tissue) on presentation. 4. Baseline non contrast CT or DWI MRI evidence of a moderate/large core defined as extensive early ischemic changes of Alberta Stroke Program Early CT score (ASPECTS) < 6 5. CT or MRI evidence that ischemia is not in anterior circulation distribution. 6. Imaging evidence that suggests, in the opinion of the investigator, the subject is not appropriate for mechanical thrombectomy intervention (e.g., inability to navigate to target lesion, moderate/large infarct with poor collateral circulation, etc.). Anesthesia exclusion criteria (relative): 1. History of Malignant Hyperthermia 2. History of allergic reaction/anaphylaxis to anesthetic drugs 3. Inability to tolerate supine position (severe CHF) 4. Chronic O2 dependence or any other known pulmonary condition that might lead to difficult extubation and prolonged mechanical ventilation including known pulmonary hypertension |
Country | Name | City | State |
---|---|---|---|
United States | UCLA Stroke Center | Los Angeles | California |
Lead Sponsor | Collaborator |
---|---|
University of California, Los Angeles | University of Southern California |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Modified Angiographic collateral circulation assessed by blinded core lab | Modified American Society of Interventional and Therapeutic Neuroradiology (ASITN) grading scale is an ordinal 0-4 scale for angiographic collateral assessment. It runs from 0 (no collaterals) to 4 (excellent collaterals) as follows: 0: No visible collaterals to the ischemic site; 1: Slow collaterals to the periphery of the ischemic site with persistence of some defect; 2 (-): rapid collaterals to the periphery of the ischemic site with collateral filling in <50% of the territory; 2 (+): rapid collaterals to the periphery of the ischemic site with collateral filling > 50% of the territory; 3: Collaterals with slow but complete angiographic blood flow of the ischemic bed by the venous phase; 4: Complete and rapid collateral blood flow to the vascular bed in the entire ischemic territory by retrograde perfusion. | Immediately prior to revascularization | |
Secondary | infarct growth assessed by blinded core lab | Infarct growth will be determined by the difference in volume (cc) between baseline and post revascularization (24-72h) infarct volume. For patients assessed with MRI at the time of arrival to emergency department (ED), baseline infarct size will be determined on diffusion weighted imaging (DWI) or apparent diffusion coefficient (ADC) imaging. Final infarct size measurement will performed using a T2 fluid attenuated inversion recovery sequence with additional reference to the DWI or ADC imaging at 24-72h after intervention. For patients assessed with CT at the time of ED arrival, baseline and final (24-72h) core infarct will be determined by RAPID perfusion imaging software. | From the first brain imaging upon arrival to emergency department (ED) up to 72 hours after intervention | |
Secondary | modified Rankin Scale assessed by a blinded investigator | The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. The scale runs from 0-6, running from perfect health without symptoms to death: 0 - No symptoms. - No significant disability. Able to carry out all usual activities, despite some symptoms. - Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. - Moderate disability. Requires some help, but able to walk unassisted. - Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. - Severe disability. Requires constant nursing care and attention, bedridden, incontinent. - Dead |
90 days after intervention | |
Secondary | safety endpoints (defined as any parenchymal hematoma (PH), subarachnoid hemorrhage (SAH), or intraventricular (IVH) associated with death, or worsening of National Institute of Health Stroke Scale score (NIHSS) by 4 or more within 24 hours) | defined as any parenchymal hematoma (PH), subarachnoid hemorrhage (SAH), or intraventricular (IVH) associated with death, or worsening of National Institute of Health Stroke Scale score (NIHSS) by 4 or more within 24 hours | from the end of thrombectoy procedure up to 24 hours after intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Enrolling by invitation |
NCT06074081 -
Comparison of 4-weeks of Motor Relearning Program and Mirror Therapy in Improving Upper Limb Motor Function in Stroke Patients.
|
N/A | |
Terminated |
NCT04039178 -
Efficacy of EMF BCI Based Device on Acute Stroke
|
N/A | |
Completed |
NCT04521634 -
Glycaemic Variability in Acute Stroke
|
||
Completed |
NCT03477188 -
The Effects of Somatosensory and Vestibular Rehabilitation Additional Conventional Therapy on Balance in Patients With Acute Stroke.
|
N/A | |
Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
Recruiting |
NCT02677415 -
Impact of Anesthesia Type on Outcome in Patients With Acute Ischemic Stroke (AIS) Undergoing Endovascular Treatment
|
N/A | |
Recruiting |
NCT01541163 -
Heart and Ischemic STrOke Relationship studY
|
N/A | |
Completed |
NCT01210729 -
Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke
|
Phase 2 | |
Recruiting |
NCT00785343 -
Study of Robot-assisted Arm Therapy for Acute Stroke Patients
|
Phase 1 | |
Completed |
NCT04779710 -
How Does Dysphagia Assessment in Acute Stroke Affect Pneumonia?
|
||
Active, not recruiting |
NCT03635749 -
Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis
|
Phase 3 | |
Recruiting |
NCT06149754 -
BraiN20® Monitoring in Acute Stroke Undergoing Thrombectomy
|
||
Recruiting |
NCT04491695 -
Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke
|
Phase 2/Phase 3 | |
Recruiting |
NCT04283760 -
Investigation of the Reliability and Validity of the Movement Imagination Questionnaire - Revised Second in Acute Stroke Patients
|
||
Recruiting |
NCT05454397 -
A Study on the Status of Nutritional Risk Screening and Nutritional Therapy in Neurology Hospitalized Stroke Patients
|
||
Completed |
NCT04488692 -
Early Functional Training in Acute Stroke Inpatient Ward
|
N/A | |
Recruiting |
NCT04214522 -
Reliability and Validity of the Kinesthetic and Visual Imagery Questionnaire in Acute Stroke Patients
|
||
Not yet recruiting |
NCT04157231 -
Essential Acute Stroke Care in Low Resource Settings: a Pilot studY
|
N/A | |
Recruiting |
NCT05469438 -
IMAS Optimization and Applicability in an Acute Stroke Setting.
|